Molecular remissions after non-myeloablative allografting for chronic myelocytic leukemia (CML).

被引：0
|
作者：
McSweeney, P
Niederwieser, D
Shizuru, J
Radich, J
Molina, A
Hegenbart, U
Chauncey, T
Sandmaier, B
Wolff, D
Blume, K
Storb, R
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Univ Leipzig, Leipzig, Germany
[4] Stanford Univ, Stanford, CA 94305 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3135
引用
收藏
页码：710A / 710A
页数：1
相关论文
共 50 条
  • [1] High rates of prolonged molecular remissions after tandem autologous non-myeloablative allografting in newly diagnosed myeloma
    Bruno, B.
    Ferrero, S.
    Drandi, D.
    Festuccia, M.
    Patriarca, F.
    Mordini, N.
    Cena, S.
    Barbero, D.
    Monitillo, L.
    Giaccone, L.
    Barbiero, S.
    Gallamini, A.
    Fanin, R.
    Passera, R.
    Palumbo, A.
    Boccadoro, M.
    Omede, P.
    Ladetto, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S200 - S201
  • [2] REDUCED INTENSITY/NON-MYELOABLATIVE ALLOGRAFTING FOR HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA
    Giaccone, L.
    Sorasio, R.
    Fiore, F.
    Bergui, L.
    Resta, I
    Omede, P.
    Caltagirone, S.
    Massaia, M.
    Boccadoro, M.
    Bruno, B.
    HAEMATOLOGICA, 2008, 93 : S99 - S99
  • [3] ATTEMPT TO INDUCE TRUE REMISSIONS IN CHRONIC MYELOCYTIC LEUKEMIA (CML)
    DOWLING, M
    HAGHBIN, M
    GEE, T
    WAKONIGV.T
    CLARKSON, B
    CANCER CHEMOTHERAPY REPORTS PART 1, 1973, 57 (01): : 102 - 102
  • [4] Molecular monitoring of minimal residual disease after non-myeloablative allografting for multiple myeloma
    Bruno, B
    Ladetto, M
    Mordini, N
    Astolfi, M
    Rotta, M
    Cimolin, L
    Compagno, M
    Veneziano, L
    Aitoro, G
    Gallamini, A
    Storb, R
    Boccadoro, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S123 - S124
  • [5] Non-myeloablative allografting from HLA-identical sibling donors for treatment of CML.
    Kerbauy, FR
    Lange, T
    Gooley, T
    Shizuru, J
    Radich, J
    Maloney, DG
    Agura, E
    Bruno, B
    Epner, E
    Chauncey, T
    Blume, K
    Storb, R
    Niederwieser, D
    Sandmaier, BM
    BLOOD, 2004, 104 (11) : 637A - 637A
  • [6] High proportion of molecular remissions after reduced intensity conditioning and allografting in CML
    Brune, M
    Wadenvik, H
    Uzunel, M
    Mattsson, J
    Mellqvist, UH
    BONE MARROW TRANSPLANTATION, 2001, 27 : S283 - S284
  • [7] Prospective Molecular Monitoring of Minimal Residual Disease after Non-Myeloablative Allografting in Newly Diagnosed Multiple Myeloma
    Bruno, Benedetto
    Ferrero, Simone
    Drandi, Daniela
    Festuccia, Moreno
    Patriarca, Francesca
    Mordini, Nicola
    Cena, Silvia
    Barbero, Daniela
    Monitillo, Luigia
    Ferrando, Federica
    Brunello, Lucia
    Fanin, Renato
    Ghione, Paola
    Omede, Paola
    Giaccone, Luisa
    Palumbo, Antonio
    Passera, Roberto
    Boccadoro, Mario
    Ladetto, Marco
    BLOOD, 2014, 124 (21)
  • [8] Chronic myelocytic leukemia (CML) in children
    Schaison, G
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1998, 43 (03): : 22 - 24
  • [9] Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma
    Ladetto, M.
    Ferrero, S.
    Drandi, D.
    Festuccia, M.
    Patriarca, F.
    Mordini, N.
    Cena, S.
    Benedetto, R.
    Guarona, G.
    Ferrando, F.
    Brunello, L.
    Ghione, P.
    Boccasavia, V.
    Fanin, R.
    Omede, P.
    Giaccone, L.
    Palumbo, A.
    Passera, R.
    Boccadoro, M.
    Bruno, B.
    LEUKEMIA, 2016, 30 (05) : 1211 - 1214
  • [10] Autografting followed by non-myeloablative allografting (NST) induces high complete remissions in high risk multiple myeloma.
    Beltrami, G
    Corsetti, MT
    Musto, P
    Carella, AM
    Scalzulli, PR
    Greco, MM
    Lerma, E
    Carella, AM
    BLOOD, 2002, 100 (11) : 622A - 622A
12345